77
Participants
Start Date
March 31, 2015
Primary Completion Date
October 31, 2018
Study Completion Date
October 31, 2018
Vayarin®, supplementation of n-3 PUFA
"Two capsules will be swallowed twice daily, 20 to 30 minutes prior to breakfast and dinner, during 12 weeks, between visit 1 and visit 2.~At the end of this period, active product will be continued, at the same dose, for a 12 week-open label period. All patients will be administered the active product."
PLACEBO
Two capsules will be swallowed twice daily, 20 to 30 minutes prior to breakfast and dinner, during 12 weeks, between visit 1 and visit 2.
CHU de Amiens, Amiens
CHU d'Angers, Angers
Hôpital des Enfants - Pellegrin, Bordeaux
CHRU Lille, Lille
Hospices Civils de Lyon, Lyon
Hôpital de la Timone, Marseille
Hôpital Necker-Enfants malades, Paris
Hôpital Robert-Debré, Paris
CHU de Rennes, Rennes
Hôpital de Hautepierre, Strasbourg
CHU de Toulouse, Toulouse
CHU de Tours, Tours
Hôpital Brabois - Rue du Morvan, Vandœuvre-lès-Nancy
Hospices Civils de Lyon
OTHER